Following AQUA and SCALE PET, the latest FDA clearance reinforces Neurophet's leadership in AI-based Alzheimer's disease ...
SAS has signed a two-year Enterprise Agreement Lite with the UK Ministry of Defence, creating a consolidated commercial framework for existing and future engagements conducted in line with public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results